Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Frequency of human papillomavirus infection in patients with gastrointestinal cancer.
Roesch-Dietlen F, Cano-Contreras AD, Sánchez-Maza YJ, Espinosa-González JM, Vázquez-Prieto MÁ, Valdés-de la O EJ, Díaz-Roesch F, Carrasco-Arroniz MÁ, Cruz-Palacios A, Grube-Pagola P, Sumoza-Toledo A, Vivanco-Cid H, Mellado-Sánchez G, Meixueiro-Daza A, Silva-Cañetas CS, Carrillo-Toledo MG, Lagunes-Torres R, Amieva-Balmori M, Gómez-Castaño PC, Reyes-Huerta JU, Remes-Troche JM. Roesch-Dietlen F, et al. Among authors: cruz palacios a. Rev Gastroenterol Mex (Engl Ed). 2018 Jul-Sep;83(3):253-258. doi: 10.1016/j.rgmx.2017.09.003. Epub 2018 Feb 16. Rev Gastroenterol Mex (Engl Ed). 2018. PMID: 29456091 Free article. English, Spanish.
[The amount of alcohol intake, upper gastrointestinal bleeding, acute renal failure and hepatic encephalopathy as the risk factors implied in the increase of patients with alcoholic hepatitis].
Higuera-de la Tijera MF, Pérez-Hernández JL, Servín-Caamaño AL, Serralde-Zúñiga AE, Cruz-Palacios A. Higuera-de la Tijera MF, et al. Among authors: cruz palacios a. Rev Gastroenterol Mex. 2009 Oct-Dec;74(4):306-13. Rev Gastroenterol Mex. 2009. PMID: 20423759 Spanish.
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
D'Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, Krueger K, Laskowski J, Li X, Lissoos T, Milata J, Morris N, Arora V, Milch C, Sandborn W, Sands BE; LUCENT Study Group. D'Haens G, et al. N Engl J Med. 2023 Jun 29;388(26):2444-2455. doi: 10.1056/NEJMoa2207940. N Engl J Med. 2023. PMID: 37379135 Clinical Trial.
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725. N Engl J Med. 2019. PMID: 31553834 Clinical Trial.